X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (81) 81
Publication (7) 7
Book Chapter (2) 2
Conference Proceeding (2) 2
Patent (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
female (39) 39
male (38) 38
middle aged (32) 32
adult (29) 29
oncology (29) 29
aged (28) 28
index medicus (28) 28
meningioma (20) 20
tumors (20) 20
clinical neurology (17) 17
surgery (17) 17
meningioma - genetics (16) 16
meningeal neoplasms - genetics (15) 15
prognosis (15) 15
classification (14) 14
meningioma - pathology (14) 14
survival (14) 14
disease progression (13) 13
cancer (12) 12
dna methylation (12) 12
meningeal neoplasms - pathology (12) 12
mutation (12) 12
brain cancer (11) 11
chromosome aberrations (11) 11
medicine & public health (11) 11
glioblastoma (10) 10
intracranial meningiomas (10) 10
neurosurgery (10) 10
retrospective studies (10) 10
temozolomide (10) 10
chemotherapy (9) 9
neoplasm recurrence, local - genetics (9) 9
recurrence (9) 9
chromosomes (8) 8
disease-free survival (8) 8
medical prognosis (8) 8
methylation (8) 8
patients (8) 8
radiotherapy (8) 8
adolescent (7) 7
aged, 80 and over (7) 7
analysis (7) 7
benign (7) 7
brain neoplasms - radiotherapy (7) 7
brain tumors (7) 7
cytogenetic analysis (7) 7
cytogenetics (7) 7
dacarbazine - analogs & derivatives (7) 7
follow-up studies (7) 7
genetic aspects (7) 7
genetic model (7) 7
gliomas (7) 7
malignant glioma (7) 7
malignant meningiomas (7) 7
pathology (7) 7
research (7) 7
surgical-treatment (7) 7
young adult (7) 7
brain (6) 6
brain neoplasms - drug therapy (6) 6
brain neoplasms - genetics (6) 6
brain-tumors (6) 6
genes (6) 6
glioblastoma multiforme (6) 6
karyotyping (6) 6
neoplasm recurrence, local - pathology (6) 6
progression (6) 6
radiology, nuclear medicine & medical imaging (6) 6
risk factors (6) 6
time factors (6) 6
adjuvant temozolomide (5) 5
antineoplastic agents, alkylating - therapeutic use (5) 5
brain neoplasms - diagnostic imaging (5) 5
brain neoplasms - mortality (5) 5
child (5) 5
chromosome deletion (5) 5
dacarbazine - therapeutic use (5) 5
deoxyribonucleic acid--dna (5) 5
dna modification methylases - genetics (5) 5
dna repair enzymes - genetics (5) 5
epigenetic (5) 5
genetics & heredity (5) 5
glioblastoma - radiotherapy (5) 5
in situ hybridization, fluorescence (5) 5
monosomy (5) 5
multiforme (5) 5
neoplasm grading (5) 5
neurology (5) 5
neurosciences (5) 5
proportional hazards models (5) 5
treatment outcome (5) 5
tumor progression (5) 5
tumor suppressor proteins - genetics (5) 5
amino acids (4) 4
care and treatment (4) 4
cell culture (4) 4
cgh (4) 4
child, preschool (4) 4
deletion (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 707 - 715
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 682 - 694
Journal Article
Neurosurgery, ISSN 0148-396X, 06/2009, Volume 64, Issue 6, pp. E1206 - E1206
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 5874 - 5880
Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of... 
MALIGNANT GLIOMA | SURVIVAL | ONCOLOGY | GLIOBLASTOMA-MULTIFORME | EUROPEAN ORGANIZATION | MGMT GENE | OLIGODENDROGLIAL TUMORS | RADIOTHERAPY | CHEMOTHERAPY | BRAIN-TUMORS | 1P/19Q LOSS | Procarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lomustine - adverse effects | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Glioma - radiotherapy | Glioma - genetics | Young Adult | DNA Methylation | Time Factors | Radiotherapy, Adjuvant - adverse effects | Glioma - pathology | Treatment Failure | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Dacarbazine - administration & dosage | Glioma - mortality | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Brain Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Procarbazine - adverse effects | Vincristine - adverse effects | Aged | Mutation | Antineoplastic Agents, Alkylating - adverse effects | Lomustine - administration & dosage | Glioma - drug therapy | Index Medicus
Journal Article
Neurosurgery, ISSN 0148-396X, 06/2009, Volume 64, Issue 6, p. E1206
Journal Article
by Capper, David and Jones, David T. W and Sill, Martin and Hovestadt, Volker and Schrimpf, Daniel and Sturm, Dominik and Koelsche, Christian and Sahm, Felix and Chavez, Lukas and Reuss, David E and Kratz, Annekathrin and Wefers, Annika K and Huang, Kristin and Pajtler, Kristian W and Schweizer, Leonille and Stichel, Damian and Olar, Adriana and Engel, Nils W and Lindenberg, Kerstin and Harter, Patrick N and Braczynski, Anne K and Plate, Karl H and Dohmen, Hildegard and Garvalov, Boyan K and Coras, Roland and Hölsken, Annett and Hewer, Ekkehard and Bewerunge-Hudler, Melanie and Schick, Matthias and Fischer, Roger and Beschorner, Rudi and Schittenhelm, Jens and Staszewski, Ori and Wani, Khalida and Varlet, Pascale and Pages, Melanie and Temming, Petra and Lohmann, Dietmar and Selt, Florian and Witt, Hendrik and Milde, Till and Witt, Olaf and Aronica, Eleonora and Giangaspero, Felice and Rushing, Elisabeth and Scheurlen, Wolfram and Geisenberger, Christoph and Rodriguez, Fausto J and Becker, Albert and Preusser, Matthias and Haberler, Christine and Bjerkvig, Rolf and Cryan, Jane and Farrell, Michael and Deckert, Martina and Hench, Jürgen and Frank, Stephan and Serrano, Jonathan and Kannan, Kasthuri and Tsirigos, Aristotelis and Brück, Wolfgang and Hofer, Silvia and Brehmer, Stefanie and Seiz-Rosenhagen, Marcel and Hänggi, Daniel and Hans, Volkmar and Rozsnoki, Stephanie and Hansford, Jordan R and Kohlhof, Patricia and Kristensen, Bjarne W and Lechner, Matt and Lopes, Beatriz and Mawrin, Christian and Ketter, Ralf and Kulozik, Andreas and Khatib, Ziad and Heppner, Frank and Koch, Arend and Jouvet, Anne and Keohane, Catherine and Mühleisen, Helmut and Mueller, Wolf and Pohl, Ute and Prinz, Marco and Benner, Axel and Zapatka, Marc and Gottardo, Nicholas G and Driever, Pablo Hernáiz and Kramm, Christof M and Müller, Hermann L and Rutkowski, Stefan and Von Hoff, Katja and Frühwald, Michael C and Gnekow, Astrid and Fleischhack, Gudrun and Tippelt, Stephan and Calaminus, Gabriele and Monoranu, Camelia-Maria and Perry, Arie and Jones, Chris and ...
Nature, ISSN 0028-0836, 03/2018, Volume 555, Issue 7697, pp. 469 - 474
Journal Article
Oncology letters, ISSN 1792-1074, 02/2018, Volume 15, Issue 2, p. 1600
Promoter methylation of , , RB transcriptional corepressor 1 ( ) and O-6-methylguanine-DNA methyltransferase ( ) impacts the prognosis of numerous glioma... 
Journal Article
ACTA NEUROCHIRURGICA, ISSN 0001-6268, 05/2019, Volume 161, Issue 5, pp. 1017 - 1024
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e94987
Meningiomas are tumors that arise from the coverings of the brain or spinal cord. 5% of the cases turn into malignant forms with aggressive clinical behavior... 
PROMOTER HYPERMETHYLATION | CYTOGENETIC PROGRESSION | ANAPLASTIC MENINGIOMAS | MULTIDISCIPLINARY SCIENCES | NUMERICAL CHROMOSOME-ABERRATIONS | TUMOR-SUPPRESSOR GENES | SQUAMOUS-CELL CARCINOMA | IN-SITU HYBRIDIZATION | HUMAN CANCERS | PROGNOSTIC-SIGNIFICANCE | MALIGNANT PROGRESSION | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Meningioma - genetics | Neoplasm Recurrence, Local - pathology | DNA Methylation | Chromosomes, Human, Pair 1 | Neoplasm Grading | Adult | Female | Tissue Inhibitor of Metalloproteinase-3 - genetics | Promoter Regions, Genetic | Meningeal Neoplasms - genetics | Meningioma - metabolism | Neoplasm Recurrence, Local - metabolism | In Situ Hybridization, Fluorescence | Disease Progression | Meningioma - pathology | Chromosome Aberrations | Neoplasm Recurrence, Local - genetics | Aged | Meningeal Neoplasms - metabolism | Meningeal Neoplasms - pathology | Care and treatment | Genetic markers | Relapse | Physiological aspects | Development and progression | Genetic aspects | Research | Meningioma | Risk factors | Cancer | Brain | Spinal cord | Brain cancer | Genes | Nervous system | Tissue inhibitor of metalloproteinase 3 | Hybridization | Neurosurgery | Histopathology | Clonal deletion | Quality | Surgery | DNA methylation | Deletion | Chromosomes | Aggressive behavior | Chromosome deletion | Risk taking | Patients | Survival | Chromosome 1 | Studies | Epigenetics | Clinical medicine | Mutation | Aberration | Methylation | Tumors
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 3/2013, Volume 125, Issue 3, pp. 351 - 358
Journal Article